Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gallium-68 OncoCAIX - Philogen

Next Previous
Drug Profile

Gallium-68 OncoCAIX - Philogen

Alternative Names: 68Ga-OncoCAIX; [68Ga]Ga-OncoCAIX

Latest Information Update: 21 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Philogen
  • Class Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics; Small molecules
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Renal cell carcinoma

Most Recent Events

  • 25 Feb 2025 Philogen plans the phase I OncoCAIX trial in Renal cell carcinoma (Diagnosis) in Italy (IV) (NCT06840548)
  • 25 Feb 2025 Preclinical trials in Renal cell carcinoma (Diagnosis) in Italy (IV), before February 2025 (Philogen pipeline, February 2025)
  • 25 Feb 2025 Pharmacodynamics data from a preclinical trial in Renal cell carcinoma released by Philogen (Philogen pipeline, February 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top